Human malignant mesothelioma of the pleura: New perspectives for diagnosis and therapy

Monaldi Archives for Chest Disease

Volumn 53, Issue 2, 1998, Pages 241-243

  Procopio, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Gene therapy; Large T antigen; Mesothelioma; Neoangiogenes; p53; Simian virus 40; Tenascin

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; PROTEIN P53; TENASCIN; VIRUS LARGE T ANTIGEN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; APTITUDE; CANCER CELL CULTURE; CELL CYCLE; CELL FUNCTION; CELL IMMORTALIZATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA SEQUENCE; GENE THERAPY; HAMSTER; HUMAN; HUMAN CELL; MOUSE; NUDE MOUSE; PLEURA MESOTHELIOMA; PROTEIN EXPRESSION; SIMIAN VIRUS 40; TRANSGENE; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; VIRUS GENOME; VIRUS RECOMBINANT;

EID: 0031874790     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Weissmann LB, Antman KH. - Incidence, presentation and promising new treatments for malignant mesothelioma. Oncology 1989; 3: 67-77.
2. Baldini EH, Recht A, Strauss GM, et al. - Patterns of failure after trimodality therapy for malignant pleural mesothioma. Ann Thorac Surg 1997; 63: 334-338.